ProfileGDS4718 / 222712_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 99% 87% 99% 98% 93% 90% 98% 99% 99% 97% 98% 96% 93% 95% 98% 98% 96% 91% 79% 98% 98% 99% 97% 98% 95% 98% 89% 98% 94% 97% 81% 99% 99% 93% 92% 97% 98% 98% 56% 97% 95% 89% 86% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.155197
GSM549102patient 115, normal, homogenized [OPG study]12.162599
GSM549104patient 119, normal, homogenized [OPG study]8.7471287
GSM549108patient 138, normal, homogenized [OPG study]11.858999
GSM549119patient 077, normal, homogenized [OPG study]11.673598
GSM549133patient 032, cancer, homogenized [OPG study]9.7557893
GSM549139patient 042, cancer, homogenized [OPG study]9.1973390
GSM549099patient 107, normal, homogenized [OPG study]11.68998
GSM549109patient 139, normal, homogenized [OPG study]12.353899
GSM549110patient 046, normal, homogenized [OPG study]12.099599
GSM549114patient 063, normal, homogenized [OPG study]11.387197
GSM549122patient 082, normal, homogenized [OPG study]11.645598
GSM549134patient 033, cancer, homogenized [OPG study]10.683596
GSM549136patient 036, cancer, homogenized [OPG study]9.8464593
GSM549140patient 044, cancer, homogenized [OPG study]10.215195
GSM549111patient 047, normal, homogenized [OPG study]11.559698
GSM549113patient 057, normal, homogenized [OPG study]11.572498
GSM549132patient 031, cancer, homogenized [OPG study]10.300296
GSM549137patient 038, cancer, homogenized [OPG study]9.2819391
GSM549142patient 047, cancer, homogenized [OPG study]7.5199179
GSM549100patient 110, normal, homogenized [OPG study]11.833498
GSM549107patient 135, normal, homogenized [OPG study]11.838598
GSM549115patient 068, normal, homogenized [OPG study]12.609699
GSM549116patient 072, normal, homogenized [OPG study]11.195397
GSM549120patient 078, normal, homogenized [OPG study]11.599398
GSM549131patient 030, cancer, homogenized [OPG study]10.3695
GSM549118patient 074, normal, homogenized [OPG study]11.750198
GSM549129patient 027, cancer, homogenized [OPG study]8.8805689
GSM549123patient 088, normal, homogenized [OPG study]11.582298
GSM549124patient 006, cancer, homogenized [OPG study]9.7356194
GSM549126patient 015, cancer, homogenized [OPG study]10.939397
GSM549128patient 025, cancer, homogenized [OPG study]8.0955781
GSM549103patient 117, normal, homogenized [OPG study]12.514499
GSM549117patient 073, normal, homogenized [OPG study]12.274599
GSM549138patient 041, cancer, homogenized [OPG study]9.8384593
GSM549141patient 045, cancer, homogenized [OPG study]9.5842492
GSM549130patient 028, cancer, homogenized [OPG study]10.801497
GSM549101patient 111, normal, homogenized [OPG study]11.746498
GSM549105patient 128, normal, homogenized [OPG study]11.526298
GSM549106patient 134, normal, homogenized [OPG study]5.8191856
GSM549112patient 048, normal, homogenized [OPG study]11.292897
GSM549125patient 011, cancer, homogenized [OPG study]10.033495
GSM549127patient 024, cancer, homogenized [OPG study]8.9791189
GSM549135patient 035, cancer, homogenized [OPG study]8.6412986